Kraig Biocraft Laboratories Inc., a leading developer of recombinant spider silk-based fibers, announced the signing of a significant production agreement aimed at scaling up its proprietary spider silk technology. This milestone builds upon the successful rollout earlier this year of Kraig
Kraig Biocraft Laboratories, Inc. announces record-setting progress in the production of its BAM-1 spider silk hybrid strain, noting unprecedented growth in silkworm size, growth, and robustness. In early June, the company accelerated its production schedule for the new BAM-1 hybrids following successful spring production trials. The first batch of these production hybrids
Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, recently announced the early start to the production season with the successful manufacture and delivery of the most recent batch of recombinant spider silk. Silk from this production cycle was processed into finished reeled raw silk and received